Search By Initial

Name Index Z

• Zosuquidar ( LY-335979 ) (Catalog# : 25127, Cas# : 167354-41-8)Zosuquidar is a potent modulator of P-glycoprotein-mediated multi-drug resistance.
• ZINC20451377 (Catalog# : 24132, Cas# : 2306303-35-3)ZINC20451377 is a small molecule that binds to hepatitis B surface antigen (HBsAg) wi
• Z-LEHD-FMK (Catalog# : 24127, Cas# : 210345-04-3)Z-LEHD-FMK is a potent, cell-permeable, and irreversible inhibitor of caspase-9. Z-LE
• Z-IETD-FMK (Catalog# : 24126, Cas# : 210344-98-2)MDK4982, also known as Z-IETD-FMK, is a potent, cell-permeable, irreversible inhibito
• Z-DEVD-fmk (Catalog# : 24125, Cas# : 210344-95-9)Z-DEVD-fmk is a cell-permeable, irreversible inhibitor of caspase-3. Caspase-3 is a c
• Zastaprazan ( JP-1366 ) (Catalog# : 24123, Cas# : 2133852-18-1)Zastaprazan, also known as JP-1366, is a proton pump inhibitor. JP-1366 mediates stro
• Zuranolone (Catalog# : 24105, Cas# : 1632051-40-1)
• Zurletrectinib (Catalog# : 24104, Cas# : 2403703-30-8)Zurletrectinib is a tyrosine kinase inhibitor with potential as an antineoplastic age
• Zelasudil (Catalog# : 24014, Cas# : 2365193-22-0)Zelasudil is a potent, highly selective and orally-active inhibitor that targets Rho-
• Ziftomenib ( KO-539 ) (Catalog# : 24013, Cas# : 2134675-36-6)Ziftomenib is an oral, potent, and selective small molecule inhibitor that targets th
• Zunsemetinib (Catalog# : 24012, Cas# : 1640282-42-3)Zunsemetinib is an investigational oral mitogen-activated protein kinase-activated pr
• Zongertinib (Catalog# : 24011, Cas# : 2728667-27-2)Zongertinib [BI 1810631] is a human epidermal growth factor receptor 2 (HER2) inhibit
• Zasocitinib (Catalog# : 24010, Cas# : 2272904-53-5)Zasocitinib is under development for the treatment of moderate to severe plaque psori
• Zilurgisertib (Catalog# : 20657, Cas# : 2173389-57-4)Zilurgisertib (earlier known as INCB 00928) is an activin receptor-like kinase-2 (ALK
• Zatolmilast (Catalog# : 20651, Cas# : 1606974-33-7)Zatolmilast is a phosphodiesterase IV inhibitor.
• Zagociguat (Catalog# : 20628, Cas# : 2201048-82-8)Zagociguat is a guanylate cyclase activator.
• Zavondemstat (Catalog# : 20610, Cas# : 1851412-93-5)Zavondemstat is a KDM4 inhibitor with potential as an antineoplastic agent.
• 1Z105 (Catalog# : 20567, Cas# : 1438280-73-9)1Z105 is a TLR4/MD2 ligand, significantly reducing the IL-6 secretion by subsequent c
• Zidesamtinib ( NVL-520 ) (Catalog# : 20524, Cas# : 2739829-00-4)Zidesamtinib ( NVL-520 ) is a novel brain-penetrant ROS1-selective tyrosine kinase in
• ZINC40099027 (ZN27) (Catalog# : 20513, Cas# : 1211825-25-0)ZINC40099027 (ZN27) is a specific focal adhesion kinase (FAK) activator that promotes
• Zotizalkib ( TPX-0131 ) (Catalog# : 20318, Cas# : 2648641-36-3)TPX-0131 is a next-generation ALK inhibitor drug candidate currently being evaluated
• Zipalertinib (Catalog# : 20317, Cas# : 1661854-97-2)Zipalertinib, also known as TAS6417, CLN-081, is a Novel EGFR Inhibitor Targeting Exo
• ZZW-115 (Catalog# : 20301, Cas# : 801991-87-7)ZZW-115is a potent NUPR1 inhibitor. ZZW-115 induces ferroptosis in a mitochondria-dep
• (3Z)-5-bromo-3-[(3-bromo-4,5-dihydroxyphenyl)methylidene]-1H-indol-2-one (Catalog# : 2071629, Cas# : 486443-73-6)LC3-mHTT-IN-AN1 (Compound AN1) is amHTT-LC3linker compound, which interacts with both
• ZK824859 (Catalog# : 2071513, Cas# : 2254001-81-3)ZK824859 is a potent uPA inhibitor as a potential treatment for multiple sclerosis. Z
• Zegocractin ( CM-4620 ) (Catalog# : 204504, Cas# : 1713240-67-5)Zegocractin (CM-4620, Auxora(TM)) is a small-molecule inhibitor of the calcium releas
• ZL0454 (Catalog# : 193281, Cas# : 2229042-77-5)ZL0454 is a potent and selective BRD4 inhibitor. ZL0454 reduces airway inflammation a
• ZM223 (Catalog# : 19352, Cas# : 2031177-48-5)ZM223 is a novel non-sulfamide NEDD8 activating enzyme inhibitor that inhibits HCT116
• Zamicastat (Catalog# : 189271, Cas# : 1080028-80-3)Zamicastat is a potent and selective dopamine β-mono-oxygenase inhibitor.
• Zardaverine (Catalog# : 185186, Cas# : 101975-10-4)Zardaverine is a Phosphodiesterase 3/4 inhibitor.